Prostate Cancer Home > Eligard for Prostate Cancer

The U.S. Food and Drug Administration (FDA) has approved Eligard® (leuprolide acetate) for prostate cancer. Specifically, this medication is used to treat disease that has spread beyond the prostate and is therefore considered to be in an advanced state. Eligard can help slow down the disease's progression and provide relief from symptoms; however, it is not a cure.
Although Eligard is used primarily for prostate cancer, it does have some unapproved ("off-label") uses. These include the treatment of breast or ovarian cancer, among other things.
(To learn more about how this drug works for prostate cancer, whether it can be prescribed for children, and other possible off-label uses, click Eligard Uses.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.